MATH vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 02, 2026

MATH

55.5
AI Score
VS
MATH Wins

HIVE

48.1
AI Score

Investment Advisor Scores

MATH

56score
Recommendation
BUY

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MATH HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth 1.1% 73.5% HIVE
Earnings Growth -63.3% -99.9% MATH
Tradestie Score 55.5/100 48.1/100 MATH
Profit Margin 3.5% -98.5% MATH
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD MATH

Relative Price Performance (Last 90 Days)

MATH 1M: +12.7% · 3M: +9.6% HIVE 1M: +12.7% · 3M: -17.5%

Current Technical Phase

MATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.5 · Price: $0.97

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.1 · Price: $3.11

Fundamentals Snapshot

Metric MATH HIVE
Market Cap
Forward P/E 0.0 -6.1
Trailing P/E 41.6
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 0.4% 0.4%
Operating Margin 0.2% -0.6%
EPS 0.02 -1.39
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MATH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.